Evidence map›Paper›PMID 21795595›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential.

Deena L Gibbons, Lucie Abeler-Dörner, Tim Raine, Il-Young Hwang, Anett Jandke, Melanie Wencker, Livija Deban, Christopher E Rudd, Peter M Irving, John H Kehrl and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. T-Cell Biology in the Female Reproductive Tract: Relevance to HIV Infection.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Human T lymphocytes at tumor sites.Seminars in immunopathology · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. HIV specific CD8Frontiers in immunology · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Deena L GibbonsPeter Gorer Department of Immunobiology, King's College London, London SE1 9RT, United Kingdom.
Lucie Abeler-Dörner
Tim Raine
Il-Young Hwang
Anett Jandke
Melanie Wencker
Livija Deban
Christopher E Rudd
Peter M Irving
John H Kehrl
Adrian C Hayday
Cancer Research UK · GBGuy's Hospital · GBKing's College London · GBNational Institutes of Health Clinical Center · USUniversity of Cambridge · GBCRUK Lung Cancer Centre of Excellence · GB

Funding

Signal Transduction In B Lymphocytes: Identification Of Key Signaling MoleculesZIAAI000739 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KEHRL, JOHN H · 2009 to 2025
$17.8M
Control Of G Protein Signaling: Role Of The RGSsZIAAI000738 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KEHRL, JOHN H · 2009 to 2025
$15.9M
CONTROL OF G PROTEIN SIGNALING: ROLE OF THE RGSSZ01AI000738 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KEHRL, JOHN H · 1996 to 2008
$3.9M
SIGNAL TRANSDUCTION IN B LYMPHOCYTES: INDENTIFICATION OF KEY SIGNALING MOLECULEZ01AI000739 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI KEHRL, JOHN H · 1996 to 2008
$1.5M
Cancer Research UKIntramural NIH HHS Z01 AI000738Intramural NIH HHS Z01 AI000739Wellcome Trust 085780
6 · The paper itself

Abstract

The RGS1 gene is associated with celiac disease, multiple sclerosis, and type I diabetes, which are all T cell-mediated pathologies, yet there is no reported analysis of regulator of G protein signaling (RGS)1 biology in human T cells. This study shows that RGS1 expression is substantially higher in T cells from human gut versus peripheral blood and that this can be exaggerated in intestinal inflammation. Elevated RGS1 levels profoundly reduce T cell migration to lymphoid-homing chemokines, whereas RGS1 depletion selectively enhances such chemotaxis in gut T cells and impairs their colitogenic potential. These findings provide a revised framework in which to view the linkage of RGS1 to inflammatory disease.

Indexed as

Cell MovementAnimalsCell SeparationChemotaxis, LeukocyteColitisFlow CytometryHumansImmunity, MucosalIntestinal MucosaMiceMice, Inbred C57BLMice, KnockoutMicroscopy, ConfocalReverse Transcriptase Polymerase Chain ReactionRGS ProteinsSignal TransductionRGS1 protein, humanRGS Proteins

Identifiers

PMID21795595
PMCPMC3166702
OpenAlexW2131107006

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.